Company Description
LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services.
The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories, as well as services related products.
The Neuromodulation segment offers VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals; and devices that deliver neuromodulation therapy for treating drug-resistant epilepsy and depression.
This segment also includes the development and clinical testing of aura6000 system for treating obstructive sleep apnea.
It serves perfusionists, neurologists, neurosurgeons, hospitals, other healthcare professionals and medical institutions, and healthcare providers.
The company sells its medical devices through direct sales representatives, agents, and independent distributors in the United States, the United Kingdom, Germany, France, Italy, the Netherlands, Spain, Belgium, Poland, Sweden, Switzerland, Austria, Norway, Portugal, Finland, Denmark, and internationally.
LivaNova PLC was incorporated in 2015 and is headquartered in Gloucester, the United Kingdom.
| Country | United Kingdom |
| Founded | 1987 |
| IPO Date | Feb 10, 1993 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 3,300 |
| CEO | Vladimir Makatsaria |
Contact Details
Address: 5220 Valiant Court, Gloucester Business Park Gloucester, GL3 4FE United Kingdom | |
| Phone | 44 1452 638 500 |
| Website | livanova.com |
Stock Details
| Ticker Symbol | LIVN |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001639691 |
| CUSIP Number | G5509L101 |
| ISIN Number | GB00BYMT0J19 |
| Employer ID | 98-1268150 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Vladimir A. Makatsaria | Chief Executive Officer and Director |
| Alex Shvartsburg C.M.A. | Chief Financial Officer |
| Natalia Sergeyevna Kozmina | Chief Human Resources Officer |
| Ahmet Tezel Ph.D. | Chief Innovation Officer |
| Lindsey Little | Vice President and Chief Accounting Officer |
| Briana Gotlin | Vice President of Investor Relations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 10, 2026 | 144 | Filing |
| Sep 4, 2026 | 144 | Filing |
| Sep 2, 2026 | 144 | Filing |
| Aug 31, 2026 | 144 | Filing |
| Aug 11, 2026 | 144 | Filing |
| Aug 6, 2026 | SCHEDULE 13G | Filing |
| Aug 5, 2026 | IRANNOTICE | Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 |
| Aug 5, 2026 | 10-Q | Quarterly Report |
| Aug 5, 2026 | 8-K | Current Report |
| Jun 15, 2026 | 144 | Filing |